Tarafenacin

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameTarafenacin
Drug Alias Nametarafenacina他非那新他利那新tarafenacinumSVT-40776
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor M3 antagonists
TargetsMuscarinic acetylcholine receptor M3
Therapy Area/IndicationsUrinary Bladder, Overactive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLaboratorios Salvat SaKwang-Dong
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSalvatKwang Dong Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsUrinary Bladder, Overactive

Other Information

ATC CodeN/A
Related LinksN/A